BSE Live
Oct 10, 16:01Prev. Close
881.70
Open Price
881.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:59Prev. Close
881.50
Open Price
881.50
Bid Price (Qty.)
904.75 (5)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Cohance Lifesciences (in Rs. Cr.) | Mar 20 | Mar 19 | |
12 mths | 5 mths | ||
INCOME | |||
Revenue From Operations [Gross] | 817.28 | 369.57 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | |
Revenue From Operations [Net] | 817.28 | 369.57 | |
Total Operating Revenues | 833.79 | 377.83 | |
Other Income | 18.12 | 0.60 | |
Total Revenue | 851.91 | 378.43 | |
EXPENSES | |||
Cost Of Materials Consumed | 240.24 | 124.52 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | |
Operating And Direct Expenses | 105.75 | 51.30 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -11.05 | -21.32 | |
Employee Benefit Expenses | 73.72 | 29.63 | |
Finance Costs | 21.81 | 2.79 | |
Depreciation And Amortisation Expenses | 23.86 | 11.50 | |
Other Expenses | 39.98 | 22.15 | |
Total Expenses | 494.32 | 220.57 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 357.59 | 157.87 | |
Exceptional Items | 0.00 | 0.00 | |
Profit/Loss Before Tax | 357.59 | 157.87 | |
Tax Expenses-Continued Operations | |||
Current Tax | 88.81 | 33.17 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | |
Deferred Tax | -1.30 | 15.42 | |
Tax For Earlier Years | 0.00 | 0.00 | |
Total Tax Expenses | 87.51 | 48.59 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 270.08 | 109.27 | |
Profit/Loss From Continuing Operations | 270.08 | 109.27 | |
Profit/Loss For The Period | 270.08 | 109.27 | |
OTHER ADDITIONAL INFORMATION | |||
EARNINGS PER SHARE | |||
Basic EPS (Rs.) | 21.22 | 8.59 | |
Diluted EPS (Rs.) | 21.22 | 8.59 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | |||
Imported Raw Materials | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | |||
Imported Stores And Spares | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | |||
Equity Share Dividend | 63.64 | 19.09 | |
Tax On Dividend | 13.08 | 3.92 | |
Equity Dividend Rate (%) | 500.00 | 150.00 |
12.06.2025
Cohance Life Standalone March 2025 Net Sales at Rs 330.17 crore, up 35.58% Y-o-Y
04.03.2025
Suven Pharma Consolidated December 2024 Net Sales at Rs 307.15 crore, up 39.73% Y-o-Y
28.11.2024
Suven Pharma Consolidated September 2024 Net Sales at Rs 257.72 crore, up 11.54% Y-o-Y
14.11.2024
Suven Pharma Standalone September 2024 Net Sales at Rs 236.06 crore, up 5.09% Y-o-Y